FDA will broaden how it evaluates new addiction treatment drugs
(By Lev Facher for STAT) The Food and Drug Administration on Monday announced a shift in the way it evaluates drugs
Read More(By Lev Facher for STAT) The Food and Drug Administration on Monday announced a shift in the way it evaluates drugs
Read More(By Fred Schulte for Kaiser Health News) As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers
Read More(By Will Stone for Kaiser Health News) It started with a rolled ankle during a routine Army training exercise. Shannon
Read MoreA new report by the consulting company Milliman prepared for America’s Health Insurance Plans (AHIP), suggest that drug rebates are
Read More(By Fred Schulte for Kaiser Health News) In a new public service ad, drugmaker Purdue Pharma suggested that taking opioids
Read More(By Ed Silverman for STAT) As political pressure on the pharmaceutical industry builds, Merck has become the latest big drug
Read More(By Ed Silverman for STAT) In response to the heated political rhetoric over the cost of prescription drugs, Novartis has decided not
Read More(By Sharon Begley for STAT) From the earliest days of the CRISPR-Cas9 era, scientists have known that the first step
Read MoreAlthough new drug shortages have declined in recent years, the Food and Drug Administration is forming a new task force
Read More(By Sara Ray and Kathleen Hoffman for STAT) History is repeating itself. Twenty years ago, a pain management crisis existed.
Read More